Ayurveda targets global wellness growth through research, standards and medical tourism

India’s Ayurveda ecosystem is pushing for export, wellness and medical-tourism growth, backed by research infrastructure, quality standards and internationally aligned regulation. The Ayush market reached $43.4 billion in 2023, while exports rose to $2.16 billion.

— Source publishedSun, 13 Sept, 2026, 14:10 IST·First seen Sun, 13 Sept, 2026, 14:17 IST·Source ET Small Business

What happened

India’s Ayurveda sector is targeting global wellness, exports and medical-tourism growth through stronger research, quality standards and internationally

Key facts

  • Ayush market grew from USD 2.85 billion in 2014 to USD 43.4 billion in 2023
  • Ayush exports rose from USD 1.09 billion to USD 2.16 billion
  • Ayush awareness: 94.8% rural and 96% urban
  • Ayush usage: 46.3% rural and 52.9% urban
  • Medical Value Travel market projected from USD 115.6 billion in 2022 to USD 286.1 billion by 2030
  • Ayush Research Portal has more than 43,000 entries

Why this matters

Consumer-health and wellness brands should assess Ayurveda partnerships, acquisitions and export platforms that pair traditional products with validated research, compliant claims and international distribution.

What to watch

  • Publication or adoption of internationally recognized Ayurveda quality, safety and labeling standards.
  • Growth in medical-tourist arrivals seeking preventive wellness, rehabilitation and chronic-condition support.
  • New import approvals, warning letters, recalls or advertising restrictions in the US, EU, UK and Gulf markets.
  • Export mix shifting from bulk herbs and low-value formulations toward branded finished goods.
  • Large pharmacy chains, beauty retailers, hotel groups or online marketplaces launching dedicated Ayurveda assortments.
  • Clinical-study output, practitioner acceptance and insurance or employer-wellness reimbursement pilots.
  • Build export-market assortments around products with documented ingredients, batch traceability, stability testing and claims substantiation.
  • Separate therapeutic, supplement, beauty and lifestyle product lines so regulatory claims and labeling can be tailored by country.
  • Partner with accredited clinics, hotels and medical-tourism operators to convert treatment visitors into retail, refill and subscription customers.
  • Use research-backed education, practitioner endorsements and transparent sourcing to position against generic herbal-wellness competitors.
  • Secure compliant marketplace and pharmacy distribution before standards tighten, prioritizing Gulf markets, North America, Europe and diaspora-heavy markets.